Medical Procedure News RSS Feed - Medical Procedure News

New nationwide survey shows steady increase in pediatric patients treated with proton radiation therapy

New nationwide survey shows steady increase in pediatric patients treated with proton radiation therapy

Results from a new nationwide survey announced today indicate a steady increase in the number of pediatric patients who are being treated with proton radiation therapy for cancerous and non-cancerous tumors. [More]
Esophageal cancer patients treated with proton therapy experience less toxic side effects

Esophageal cancer patients treated with proton therapy experience less toxic side effects

New research by scientists at the University of Maryland School of Medicine has found that esophageal cancer patients treated with proton therapy experienced significantly less toxic side effects than patients treated with older radiation therapies. [More]

First commercial procedure performed using Senza system for delivering Nevro's HF10 therapy

Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has been performed in the United States under the company's May 8th, 2015 FDA approval for commercial use of the Senza spinal cord stimulation (SCS) system, which delivers Nevro's proprietary HF10 therapy. [More]
nTMS analysis of motor areas improves prognosis of patients with malignant brain tumors

nTMS analysis of motor areas improves prognosis of patients with malignant brain tumors

A method known as navigated transcranial magnetic stimulation (nTMS) has been gaining importance in neurosurgery for some time now. [More]
Omeros receives EMA CHMP positive opinion for Omidria for cataract, IOL replacement surgery

Omeros receives EMA CHMP positive opinion for Omidria for cataract, IOL replacement surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Omidria® (phenylephrine and ketorolac injection) 1%/0.3%. [More]
Researchers map out surgical anatomy, approaches for auditory brainstem implant placement

Researchers map out surgical anatomy, approaches for auditory brainstem implant placement

A technique called auditory brainstem implantation can restore hearing for patients who can't benefit from cochlear implants. A team of US and Japanese experts has mapped out the surgical anatomy and approaches for auditory brainstem implantation in the June issue of Operative Neurosurgery, published on behalf of the Congress of Neurological Surgeons by Wolters Kluwer. [More]
Scripps Proton Therapy Center reports exceptional results in treating patients with pencil-beam scanning

Scripps Proton Therapy Center reports exceptional results in treating patients with pencil-beam scanning

The nation's first and only proton therapy center to treat patients exclusively with pencil-beam scanning is reporting exceptional results in delivering cancer treatment since opening for patient care just more than a year ago. [More]
Stereotactic body radiotherapy appears to be safe, effective for some pancreatic cancer patients

Stereotactic body radiotherapy appears to be safe, effective for some pancreatic cancer patients

Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose radiation treatment, called stereotactic body radiotherapy, appears to be safe and as effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread. [More]
U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

Oraya Therapy was introduced first in the U.K., followed by Switzerland and Germany. The therapy is intended as a one-time, non-invasive treatment that maintains vision with fewer anti-vascular endothelial growth factor (anti-VEGF) injections into the eye... [More]
Cynosure obtains FDA approval to market SculpSure for non-invasive lipolysis treatment

Cynosure obtains FDA approval to market SculpSure for non-invasive lipolysis treatment

Cynosure, Inc. a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure, the world's first hyperthermic laser treatment for non-invasive lipolysis of the flanks. [More]
Patients undergoing percutaneous coronary intervention at higher risk for sleep apnea

Patients undergoing percutaneous coronary intervention at higher risk for sleep apnea

Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference. [More]
The Royal College of Surgeons Edinburgh endorses Touch Surgery, a mobile cognitive simulation and rehearsal platform for surgeons

The Royal College of Surgeons Edinburgh endorses Touch Surgery, a mobile cognitive simulation and rehearsal platform for surgeons

Touch Surgery is officially the largest community of surgeons practising and rehearsing virtual surgery, and is accessible via any smart device on both iOS and Android platforms. .. [More]
Linkam and Cambridge IVF work on the development of new protocols for sperm testing

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

IVF is becoming increasingly important as fertility and birth rates fall in developed countries. Ensuring patients get the right treatment is important both from an emotional and financial perspective... [More]
Lumenis and top urologists to host instructive workshop series at AUA 2015

Lumenis and top urologists to host instructive workshop series at AUA 2015

Lumenis Ltd., the world's largest energy-based medical device company for surgical, ophthalmology, and aesthetic applications announced today that the company will host an educational symposium, in collaboration with nationally distinguished urologists, and an instructive workshop series at the American Urological Association's (AUA) 2015 Annual Meeting, being held in New Orleans, La., from May 15 – 19, 2015. [More]

HRS 2015: Additional data supports SJM quadripolar cardiac resynchronization therapy system

St. Jude Medical, Inc., a global medical device company, today announced the presentation of important data around its SJM™ Quadra CRT System during the Heart Rhythm Society's (HRS) 36th annual scientific sessions. Multiple presentations showcase improved clinical outcomes, increased survival and better cost utilization with the St. Jude Medical quadripolar cardiac resynchronization therapy (CRT) system. [More]
Current fee-for-service models in U.S. healthcare may jeopardize prostate surgery patients

Current fee-for-service models in U.S. healthcare may jeopardize prostate surgery patients

A "perverse disincentive" for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a new study led by Henry Ford Hospital researchers. [More]
Findings support use of high-flow nasal oxygen therapy to treat postoperative respiratory failure

Findings support use of high-flow nasal oxygen therapy to treat postoperative respiratory failure

A relatively new, easier to implement, and better-tolerated method to provide supplemental oxygen to patients at risk of respiratory failure after surgery did not result in a worse rate of treatment failure compared to a more commonly used method, according to a study appearing in JAMA. [More]
Weight loss can improve outcomes in lung transplant patients

Weight loss can improve outcomes in lung transplant patients

Obesity is a complicating factor for many surgical patients. In a recent study published in the Journal of Heart and Lung Transplantation, Mayo Clinic researchers have shown that losing weight can have a positive impact on outcomes for lung transplant patients. [More]
New research confirms the efficacy of Hilterapia laser technique for treating tendinitis

New research confirms the efficacy of Hilterapia laser technique for treating tendinitis

A recent study conducted by the researchers Gabrhel J., Popracová Z., Tauchmannová H. and M. Nemšák on the application of Hilterapia®, produced by ASAlaser - a company for over 30 years at the forefront of the study and development of therapeutic laser solutions - in Achilles tendinopathy and in serious tendons and ligaments disorders has confirmed its full effect. [More]
Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE Urologic Hydrophilic Coated Guidewire, a device cleared by the FDA for urological use. [More]
Advertisement
Advertisement